chrisvoncsefalvay/vaers-outcomes huggingface dataset:
08/04/2003: DTAP left deltoid (MMR AND IPV other sites)-non-tender-red deltoid with hachrest blister.  Resolved ilate to left pedtaldar.  08/0-2 satellite lesions (blister 1 cm erythema) at right leg-started ceplular.  Recovering at this time.
I had like a cold, slight cough and that's it. It lasted maybe four or five days. I tested positive for the COVID-19 virus at home on 30JAN2023. I was prescribed Paxlovid by my Doctor.
I couldn''t walk this morning; I can''t walk on my feet very well; My feet is, they had the worst, they feel are stabbing them with a knife; My feet hurt so bad, it hurts really bad to walk on them; I threw up; This is a spontaneous report from a contactable consumer or other non hcp. A 71-years-old female patient received bnt162b2 (BNT162B2), (Formulation: Solution for injection, Batch/Lot Number was Unknown, Expiration Date: Unknown) as DOSE 3 (BOOSTER), SINGLE via an unspecified route of administration, administered in Arm Left on 28Sep2021 for covid-19 immunisation.  Medical history included diabetes mellitus (I just had diabetes 2 and I used the Cpat at night twice and I guess that was about the worst thing I got) from an unknown date and unknown if ongoing Verbatim: Diabetes II, blood pressure measurement from an unknown date and unknown if ongoing, optic ischaemic neuropathy patient also added that anything that would cause the optical nerve to 'swell' would hurt me because the bone structure can't handle it and it caused about 75 percent of blindness in one eye, that's the worst thing I had I think from an unknown date and unknown if ongoing. Concomitant medication(s) included glimepiride (Januvia), sitagliptin phosphate, metformin taken for diabetes mellitus, start and stop date were not reported; lisinopril taken for blood pressure measurement, start and stop date were not reported; gabapentin taken for neuropathy peripheral, start and stop date were not reported; acetylsalicylic acid taken for an unspecified indication, start and stop date were not reported. This historical vaccine was bnt162b2 (BNT162B2), (Formulation: Solution for injection, Batch/Lot Number was EN6200, Expiration Date: Unknown) as dose 2, single via an unspecified route of administration on 01Mar2021 for covid-19 immunisation and also received bnt162b2 (BNT162B2), (Formulation: Solution for injection, Batch/Lot Number was EN6200, Expiration Date: Unknown) as dose 1, single via an unspecified route of administration, administered on an unknown date for covid-19 immunisation. On 29Sep2021  the patient had events reported as: I couldn't walk this morning; i can't walk on my feet very well, my feet is, they had the worst, they feel are stabbing them with a knife; my feet hurt so bad, it hurts really bad to walk on them, on 28Sep2021  i threw up. Therapeutic measures patient stated that since it's like I can't walk on my feet very well if I took, the only thing I have had this morning is 2 Tylenols, but if I took the 'Pension D' (further clarification unknown for the name of the medication hence suspect not captured for MI query) do you think that would help. The outcome of events that I couldn't walk this morning; i can't walk on my feet very well, my feet is, they had the worst, they feel are stabbing them with a knife; my feet hurt so bad, it hurts really bad to walk on them was not recovered. and the outcome of i threw up was unknown.
This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and administered on 28MAR2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-MAR-2022) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Mar-2022 at 12:48 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Mar-2022 at 12:48 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and administered on 28MAR2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-MAR-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and administered on 28MAR2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-MAR-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications reported by reporter. Treatment medication not reported. The patient took booster dose on 28-Mar-2022 at 12:48:41. This case was linked to MOD-2022-542869 (Patient Link).
The day after I received the vaccine around 6pm I suddenly felt strange. I stood up and began to walk and started stumbling and felt dizzy. Everything around me was spinning and wouldn?t stop. Even if I sat down or laid down everything was spinning. The constant spinning caused me to vomit. This continued to happen for 24 hours and on 9/30/2021  I went to an urgent care. The urgent care instructed me to go to the hospital. The hospital did bloodwork, an mri, and a cat scan, along with several neurological tests. Everything was normal. By the next day the spinning had stopped and after some sleep I was able to feel normal again. On 10/1/2021 around 9pm I started feel strange again. The spinning was not as intense, but present. I have never had symptoms of vertigo my entire life until reviving the Covid vaccine. I?m not sure if I am going to continue to experience these symptoms, I am very nervous to get the second dose.
Site: Pain at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: Patient states that she is still feeling pain in left arm after injection, 1 month later. Stating that she is having limited Range of motion and experiences bouts of pain. Patient has seen MD
noc of 14MAY92 irritability, sweating, loss of appetite, felt real hot, did not take temp 15, 16, 17MAAY92 felt better during day, but @ noc, irritability & felt hot; 18MAY92 did not sleep, on & off crying last noc & today, t101;
headache, muscle aches and pain over most of the body, weak to stand and fever of 101 for the day (Saturday, May 30, 2020
This patient had swelling and redness involving 2/3 of the right arm (site of injection).
2 cm area of redness and induration (L) upper arm. Positive tenderness. No warmth.
Chills/shivering - 3 hours of nonstop shivering body aches - 5 days every bone  and muscle in entire body gastritis - ER for severe stomach pain that lasted for 4 days headaches sweating
Information has been received from a certified medical assistant concerning a 19 year old female, with no known medical history reported, who on 16-AUG-2006 was vaccinated intramuscular with a 0.5 mL dose of Pneumovax 23 (Lot# unknown). Concomitant therapy included fluticasone propionate (FLONASE), ethinyl estradiol/mestranol/norethindron (ORTHO-NOVUM), albuterol and fluticasone propionate (+) salmeterol xinafoate (ADVAIR). The medical assistant reported that the patient had an injection site reaction. On the day of the vaccination, 16-AUG-2006, the patient developed nausea, vomiting, and fever 102.6 degrees F. There was also 5 inches in diameter of swollen area at the injection site. It was also reported that she went to work for a half a day. The medical assistant and the doctor felt that the patient's experience was serious because she did have to miss some work due to her symptoms. The clinical outcome was reported as recovering. No product quality complaint was involved. The patient's experience, injection site reaction, nausea, vomiting, and fever 102.6 degrees F, and 5 inches in diameter of swollen area at the injection site, were considered to be an other important medical event by the reporter. Additional information has been requested.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th January 2020, the patient received the 1st dose of Shingrix. On 9th January 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On 13th January 2020, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and experienced pain in arm, body temperature increased and chills. The reporter consented to follow up. For tolerance to 2nd dose refer linked case US2020AMR146116, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR146116:same reporter
COVID-19 INFECTION Narrative: Pt received first dose of Moderna then RN was contacted for a report of patient having a mild case in early February. Pt was told by hospital at discharge that he should not receive 2nd dose until 5/2021.
This spontaneous report was received from a non-pregnant 23 year old female patient with no drug reactions or allergies and no pertinent medical history, who was reporting on herself. The patient stated that she received three doses of GARDASIL, 0.5 ml, intramuscularly, (lot number and expiration date were not provided). The first dose was administered on 27-OCT-2015, the second dose was received on 01-DEC-2015 and the third dose was administered on 02-MAR-2016. There were no concomitant medications reported. The patient stated that since the last dose, she had felt fatigued, experienced injection sire soreness and bruising (on 02-MAR-2016). The patient did not seek medical attention. No laboratory diagnostic studies were performed. No treatment was given for the events. The outcome of injection site soreness and bruising and feeling fatigued was reported as not recovered. The relatedness between the events and suspect therapy was not provided. Additional information has been requested.
Clinical Narrative: Patient was treated for COVID-19 pneumonia, of which she was started on breathing treatments, steroids with Decadron, guaifenesin, and she completed 5 days of remdesivir this morning.  She is presently afebrile, no shortness of breaths she is on room air saturating 95% and she is anxious to be discharged back home she was started on empirical antibiotics with ceftriaxone and Zithromax for possible superimposed bacterial pneumonia, completed 45 days of antibiotic Chest x-ray has shown blunting of the costophrenic angle on the right, consent for pleural effusion and ultrasound was done this morning which shows very small right pleural effusion Patient will be discharged to follow closely with her family physician
Very red, hives like rash on her face and upper torso; Very red, hives like rash on her face and upper torso; Very red, hives like rash on her face and upper torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Very red, hives like rash on her face and upper torso), URTICARIA (Very red, hives like rash on her face and upper torso) and RASH (Very red, hives like rash on her face and upper torso) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Very red, hives like rash on her face and upper torso), URTICARIA (Very red, hives like rash on her face and upper torso) and RASH (Very red, hives like rash on her face and upper torso). At the time of the report, RASH ERYTHEMATOUS (Very red, hives like rash on her face and upper torso), URTICARIA (Very red, hives like rash on her face and upper torso) and RASH (Very red, hives like rash on her face and upper torso) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment and Concomitant medicines were reported
vaccination adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (vaccination adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU VACCINE VII.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (vaccination adverse event). At the time of the report, VACCINATION COMPLICATION (vaccination adverse event) outcome was unknown. Not Provided          No information about concomitant and treatment medication was provided by reporter.
assume she had covid as well; assume she had covid as well; Feeling bad; Upper respiratory infection; This is a spontaneous report from a contactable consumer (patient). This consumer reported different events for two patients (herself and her husband), this is the first of two reports.  A 71-year-old female patient received 1st dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), intramuscular in left arm on 12Jan2021 16:30 at single dose for preventing covid. Medical history and concomitant medications were none. No prior vaccinations (within 4 weeks). She and her husband both received their first dose on 12Jan2021. Stated they both have covid. She was feeling bad last Friday (15Jan2021) and she went to urgent care and had a rapid test done that day that came back negative. Her husband went to urgent care this morning and had a rapid test that came back positive. She was told to assume she had covid as well. When she went to physician office for urgent care last Friday (15Jan2021), she was given medication for what they thought was an upper respiratory infection since her test last week came back negative. She was feeling better. The patient underwent lab tests and procedures which included Covid: negative on 15Jan2021. The outcome of feeling bad was recovering, for the rest of events outcome was unknown. No emergency room visit.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021078480 same reporter/drug, similar events, different patient.
RED 3 INCH CIRCULAR RASH AT INJECTION SITE THAT APPEARED THE NEXT MORNING AFTER GETTING SHOT. CONTACTING HER DR. OFFICE AND THE NP/PA PRESCRIBED HER A MEDROL DP, AND USE COLD COMPRESSES. I ADVISED PT TO CALL ME TOMM. TO CHECK ON HER AND CALL IMMEDIATELY TO GET HELP IF IT WORSENS.  11/3/08 Per patient-no permanant disability. Pt recovered from rash. No f/u required
Information has been received from a registered nurse concerning a 23 year old female office employee in her office with drug reactions/allergies and pertinent medical history reported as unspecified who on an unspecified date was vaccinated with first dose of Gardasil (yeast) (lot# not reported) intramuscularly. Concomitant therapy was unspecified. On an unspecified date, the patient was vaccinated in the gluteal area and she experienced injection site pain. The patient sought medical attention. At the time of reporting, the outcome of the event was unspecified. No other information was provided. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent conditions or medical history were provided. On an unspecified date in 2016 (reported as "on or after 03-MAR-2016"), the patient was vaccinated with an improperly stored dose of ROTATEQ injection (lot # M002252 with expiry date: 28-FEB-2017, orally; strength, dose and site administration were unspecified). No concomitant therapy was reported. The administered vaccine underwent the temperature excursion at 8.3 degrees Celsius for 19 minutes. There was no previous temperature excursion. It was a case of a "data logger". No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
pt recvd vax; appeared in hlth ofc w/ fine red rash on front of lower & upper legs; pt reported swollen neck glands on 18jan95 w/ flu-like sxs
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided          Concomitant medication was not reported.  It was unknown if patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient received vaccine past the beyond used by date. Treatment medication was not reported.
approx 2 hrs following immun, fever 103, toward evening became lethargic, @ bedtime c/o bad h/a, stiff neck; middle of noc woke again w/fever & h/a was given APAP; 2 periods of staring, screaming, eyes seemed dilated was disoriented;
Severe headache, extreme fever, intense chills, muscle aches across entire body, extreme fatigue... symptoms starting around 2am on 02/06/2021 and still happening today (02/07/2021)  in the evening.
Loss of partial vision on left eye, micro bleeding in brain, currently going through acupuncture treatments, not yet recovered
The child was given the vaccine in the right arm. The vaccination was completed at 12:39 pm. A few minutes later after the vaccination, the  mom states that the daughter slumped over while waiting in the waiting area. The child may have passed out for a few seconds.  The child seems  a little dizzy and disoriented after the vaccination while waiting in the waiting area after the vaccination. She was not verbally responding to questions. 911 was  called and EMT came to evaluate the child. EMT checked out the child's vitals and the child's vital was within normal limits. The child did not go to the hospital and was able to leave on her own from the pharmacy after the EMT evaluated her.
mild elevation of his sed rate and leukocytosis; mild elevation of his sed rate and leukocytosis; myalgia (was reported as worsened); Arthralgia; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; This is a spontaneous report from a contactable physician (patient). A 76-years-old male patient received bnt162b2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 23Dec2020 at single dose on deltoid Right for covid-19 immunisation. Medical history included ongoing type 2 diabetes mellitus (diagnosed about 8 years ago). There were no concomitant medications. Patient developed myalgia on 27Dec2020 and arthralgia on 28Dec2020. Patient also experience ten days later and still having pain/ started in neck and migrated to his back, the buttocks and gluteal and quadriceps area in Dec2020. He had labs a few days ago. He had a mild elevation of his sed rate and leukocytosis. Events myalgia and arthralgia considered serious due to medically significant. Outcome of events myalgia (was reported as worsened) and arthralgia was not recovered.   Information about batch/lot number has been requested.; Sender's Comments: Based on the time association, the events myalgia and arthralgia are possibly related to suspect bnt162b2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
His First shot on 3/8/21 only had a  slight sore arm in injection area. On 4/13/21, (9days later) he woke up in  the morning to find a rash/hives over his upper torso.  It   itched and in the following days spread over his complete torso, arms, back and lower torso. ,We now see a few on his legs and face, also and his body looks like I have painted his body and it covers all areas.  We have checked with His Dermatologist, his Internist and nurse who have noted this response to the second dose and suggested Zyrtec and Calimine lotion  for the itching.  At this time he still has the rash over all of his body.  I can send a picture if you like.  I would say this is a severe reaction for a 2nd shot.
Pain, swelling of both hands worsening over the next five days.  Treated by the personal physician on 10/11/2010 with Medrol Dose Pak. Symptoms decreased that evening.
Information has been received from a RN concerning a pt who on 20Mar96 was vaccinated with a dose of varicella virus vaccine live (lot 608578/0389B). Subsequently, on 19Dec00, the pt developed chickenpox. The pt was seen in the office. The reporter also indicated that 30 other pts were vaccinated with varicella virus vaccine live and developed chickenpox (WAES0409USA00600, WAES0409USA01045, WAES0409USA01046, WAES0409USA01047, WAES0409USA01048, WAES0409USA01049, WAES0409USA01050, WAES0409USA01051, WAES0409USA01052, WAES0409USA01053, WAES0409USA01054, WAES0409USA01055, WAES0409USA01056, WAES0409USA01057, WAES0409USA01058, WAES0409USA01059, WAES0409USA01060, WAES0409USA01061, WAES0409USA01062, WAES0409USA01064, WAES0409USA01065, WAES0409USA01066, WAES0409USA01067, WAES0409USA01068, WAES0409USA01069, WAES0409USA01070, WAES0409USA01071, WAES0409USA01072, WAES0409USA01073, WAES0409USA01074). No further information is expected.
Fever appx 102.5, severe migraine, muscle tension in L arm and through chest/back, rapid heart rate, light headed, nausea
It was reported that a male patient received a TD Adult vaccination on 21 Feb 2001. Reportedly after the vaccination the patient developed a fever of 103F, general malaise and body aches which still persist 2 days after vaccination.
I am the reporter of this event.  I am a pharmacist and received a needle stick. I was advised by our Market Director to place a VAERS report.   The actual person who received the shot is not involved with this report or the event.  I intend to have blood work done